Join
Acumen Research
@acumenresearchmarket2019
Acumen Research
February 12, 2020

Biosurgery Market Size Poised to Touch US$19,940.4 Mn by 2026

The global biosurgery market is projected to grow from USD 19,940.4 million by 2019 - 2026 and growing at a CAGR of around 7.9% from 2019 to 2026.

In 2018, North America held the highest market share and is expected to continue with dominance over the forecast period. The region is gaining positive growth owing to the presence of advanced healthcare infrastructure and easy accessibility to advance technology in the region. The increased awareness and the increasing geriatric population in the region are accelerating market growth. The U.S. contributed to the major share in the regional market owing to the increasing number of surgeries. In addition, increasing government funding and investment is further propelling the regional market growth. For instance, a subsidiary of Johnson & Johnson Medical Devices Companies, Ethicon has announced 510(k) clearances in June 2019 for its Vistaseal dual applicator, a tissue sealant product for use in open and laparoscopic surgery. This was the first clearance since the company partnered with Spain-based Grifols, a leading provider of plasma-derived medicines.

By product, surgical sealants are growing at a significant rate and are expected to dominate the market over the forecast period. Increasing cases of sports-related injuries and spinal ailments are favoring the segment growth. The high prevalence of lifestyle diseases coupled with the rising number of surgeries performed worldwide is further expected to create potential demand over the forecast period.

On the basis of source, natural/biologic products held the largest market share owing to the presence of a wide range of products in the market. For instance, Grifols, a top provider of plasma-derived medicines to treat life-threatening diseases, introduced VISTASEAL™ fibrin sealant with Ethicon Inc. to provide plasma-protein-based solutions to manage surgical bleeding.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1733

Biosurgery Market (By Product: Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments, Bone Graft Attachments, Others; By Source: Natural/Biologics Products, Synthetics Products; By Application: General Surgery, Orthopedic Surgery, Cardiovascular surgery, Neurological Surgery, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

By application, general surgery accounted for the largest market share in the year 2018, also expected to be the fastest-growing segment during the forecast period. The increasing number of surgical cases along with the rising prevalence of chronic diseases is accelerating the segment growth. The technological advancements in the field, along with the rising adoption of advanced surgeries in the developing economies are further contributing to the segment growth.

Some of the leading competitors are Ethicon Inc., Sanofi, Baxter, Integra LifeSciences Corporation, Medtronic Plc, B. Braun Melsungen AG, Pfizer Inc, Stryker, and CSL Behring. The companies are involved in mergers, acquisition & partnerships and new product developments to expand the market share.

Some of the key observations regarding biosurgery industry include:

  • Aroa Biosurgery and Hydrofera Team up to launch Appulse in North America. Hydrofera, LLC is the United States-based medical products company and Aroa Biosurgery is a New Zealand based biomedical company.
  • In April 2018, US-based company Integra Life Sciences Holdings Corporation has launched the Codman Specialty Surgical product portfolio
  • In April 2017, Baxter International Inc., US-based company enhanced it's FLOSEAL and TISSEEL hemostatic product OFFERINGS
  • Medtronic launched the Infuse Bone Graft in September 2017, which is a recombinant human bone morphogenetic protein-2 (rhBMP-2) applied to an absorbable collagen sponge carrier (ACS), which helps in stimulating natural bone formation.
  • Arch Therapeutics, Inc., a biotechnology company has provided a corporate update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY. The corporate update was provided by the CEO, Terrence W. Norchi, which includes the business focus on applications including Dermal Sciences, Biosurgery, and or certain pipeline opportunities in collaboration with its partner among others.
  • Aroa Biosurgery, headquartered in Auckland, is a privately held tissue-regeneration company. The company grows into an additional market and has presented positive outcomes of a new clinical study in Canada performed using its core wound product Endoform Natural®. The product has been launched in the Canadian market in October 2019, along with Endoform Antimicrobial®.
  • TELA Bio and Aroa Biosurgery were granted EC Certification (CE Mark) for OviTex RBSs in the European Union. The OviTex RBSs is a distinct class of surgical mesh that integrates both biologic and synthetic materials to maintain flexibility without compromising on strength.

Market Segmentation

Market By Product

  • Surgical Sealants
  • Hemostatic Agents
  • Adhesion Barriers
  • Soft Tissue Attachments
  • Bone Graft Attachments
  • Others

Market By Source

  • Natural/Biologics Products
  • Synthetics Products

Market By Application

  • General Surgery
  • Orthopedic Surgery
  • Cardiovascular surgery
  • Neurological Surgery
  • Others

Market By Geography

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • Germany
  • France
  • Spain
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

- What is the overall structure of the market?

- What was the historical value and what is the forecasted value of the market?

- What are the key product level trends in the market?

- What are the market level trends in the market?

- Which of the market players are leading and what are their key differential strategies to retain their stronghold?

- Which are the most lucrative regions in the market space?

Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1733

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Biosurgery
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Biosurgery Market By Product
1.2.2.1. Global Biosurgery Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Biosurgery Market Revenue Share By Product in 2018
1.2.2.3. Surgical Sealants
1.2.2.4. Hemostatic Agents
1.2.2.5. Adhesion Barriers
1.2.2.6. Soft Tissue Attachments
1.2.2.7. Bone Graft Attachments
1.2.2.8. Others
1.2.3. Biosurgery Market By Source
1.2.3.1. Global Biosurgery Market Revenue and Growth Rate Comparison By Source (2015-2026)
1.2.3.2. Natural/Biologics Products
1.2.3.3. Synthetics Products
1.2.4. Biosurgery Market By Application
1.2.4.1. Global Biosurgery Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. General Surgery
1.2.4.3. Orthopedic Surgery
1.2.4.4. Cardiovascular surgery
1.2.4.5. Neurological Surgery
1.2.4.6. Others
1.2.5. Biosurgery Market By Geography
1.2.5.1. Global Biosurgery Market Revenue and Growth Rate Comparison By Geography (2015-2026)
1.2.5.2. North America Biosurgery Market Revenue and Growth Rate(2015-2026)
1.2.5.3. Europe Biosurgery Market Revenue and Growth Rate(2015-2026)
1.2.5.4. Asia-Pacific Biosurgery Market Revenue and Growth Rate(2015-2026)
1.2.5.5. Latin America Biosurgery Market Revenue and Growth Rate(2015-2026)
1.2.5.6. Middle East and Africa (MEA) Biosurgery Market Revenue and Growth Rate(2015-2026)

CHAPTER 2. MARKET DYNAMICSAND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Biosurgery Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Biosurgery Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Biosurgery Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Biosurgery Major Manufacturers in 2018

CHAPTER 4. BIOSURGERY MARKET BY PRODUCT
4.1. Global Biosurgery Revenue By Product
4.2. Surgical Sealants
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Hemostatic Agents
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Adhesion Barriers
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Soft Tissue Attachments
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Bone Graft Attachments
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Others
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. BIOSURGERY MARKET BY SOURCE
5.1. Global Biosurgery Revenue By Source
5.2. Natural/Biologics Products
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Synthetics Products
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. BIOSURGERY MARKET BY APPLICATION
6.1. Global Biosurgery Revenue By Application
6.2. General Surgery
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Orthopedic Surgery
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Cardiovascular surgery
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Neurological Surgery
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Others
6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA BIOSURGERY MARKET BY COUNTRY
7.1. North America Biosurgery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Biosurgery Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Biosurgery Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE BIOSURGERY MARKET BY COUNTRY
8.1. Europe Biosurgery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Biosurgery Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC BIOSURGERY MARKET BY COUNTRY
9.1. Asia-Pacific Biosurgery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Biosurgery Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA BIOSURGERY MARKET BY COUNTRY
10.1. Latin America Biosurgery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Biosurgery Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA BIOSURGERY MARKET BY COUNTRY
11.1. Middle East & Africa Biosurgery Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East & Africa Biosurgery Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5. Rest of Middle East & Africa
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Source, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Ethicon
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Type Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Sanofi
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Type Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Baxter
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Type Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Integra LifeSciences Corporation
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Type Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Medtronic Plc
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Type Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. B. Braun Melsungen AG
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Type Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Pfizer Inc
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Type Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Stryker
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Type Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. CSL
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Type Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Others
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Type Portfolio
12.10.5. Key Developments
12.10.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/1733

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Contact Us:

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com

Follow Us: LinkedIN | Twitter

Acumen Research
February 12, 2020, 13:22
0 views
0 reactions